Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...

The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity and improve patient outcomes. Traditional oral or IV drugs often face poor ...

If you're looking for companies quietly shaping the next wave of AI-driven productivity, UiPath deserves a closer look.

For long-term investors looking to ride the wave of AI-powered productivity, UiPath might just be one of the more underappreciated names worth watching closely.

The standing of UiPath among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ...

Geoffrey Seiler has positions in Alphabet, GitLab, and UiPath. The Motley Fool has positions in and recommends Alphabet, Datadog, GitLab, Nvidia, Snowflake, and UiPath. The Motley Fool has a ...

Platform thinking provides a sustainable path forward. It creates QE ecosystems that scale, empower teams and deliver ...

In an era where software must be fast, flawless, and secure, testing is no longer a supporting function; it is at the ...